Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (13 ops.)
Latest filing published 20 Apr 2026 for Alamar Biosciences, Inc.. Read the official filing
Filing timeline
BuySaleJustin J. McAnear
Insider track record
Disclosed buys
1
Disclosed sells
13
T+90 hit rate
0%
T+90 mean return
-27.6%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Justin J. McAnear: trading record in brief
Filings by Justin J. McAnear span 2 companies, the busiest being 10x Genomics, Inc. and Alamar Biosciences, Inc. We count 29 filings; the first trade dates from 19 March 2021 and the latest from 20 April 2026.
Both buying and selling appear: 1 purchase worth €6,163, against 13 sales worth €605k. Netting one side against the other leaves €599k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 6 share grants and 9 option exercises.
The latest filing, published on 20 April 2026, reports a share grant in Alamar Biosciences, Inc. The clock since the last published purchase (17 May 2022) now reads 1,615 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Justin J. McAnear
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations29 total
37,220 shares0Common StockSEC:0001786386-26-000006:0
2,961 shares@ US$22.52974.1% of flowClass A Common StockSEC:0001610717-24-000453:0
2,936 shares@ US$24.30364.5% of flowClass A Common StockSEC:0001610717-24-000259:0
53,312 shares0Class A Common StockSEC:0001610717-24-000184:0
1,865 shares@ US$46.34435.5% of flowClass A Common StockSEC:0001610717-24-000090:0
1,679 shares@ US$43.33674.6% of flowClass A Common StockSEC:0001610717-23-000365:0
1,678 shares@ US$45.78114.9% of flowClass A Common StockSEC:0001610717-23-000237:0
194 shares@ US$55.06950.7% of flowClass A Common StockSEC:0001610717-23-000064:0
25,991 shares0Class A Common StockSEC:0001140361-23-013504:0
1,245 shares@ US$47.75333.8% of flowClass A Common StockSEC:0001567619-23-003782:0
686 shares@ US$34.06511.6% of flowClass A Common StockSEC:0001567619-22-020869:0
20,297 shares0Class A Common StockSEC:0001567619-22-017565:0
987 shares@ US$35.19132.4% of flowClass A Common StockSEC:0001567619-22-016677:0
967 shares@ US$48.76410.0021% mcap4.5% of flowClass A Common StockSEC:0001567619-22-011713:0
158 shares@ US$40.48550.0003% mcap0.6% of flowClass A Common StockSEC:0001567619-22-011123:0
Canonical exit: 11 Aug 2022 (T+90)
21,357 shares0Class A Common StockSEC:0001567619-22-007440:0
288 shares@ US$78.59940.0010% mcap2.0% of flowClass A Common StockSEC:0001567619-22-005520:0
10,000 shares@ US$5.040.0021% mcap4.5% of flowClass A Common StockSEC:0001567619-22-000622:0
10,000 shares@ US$5.044.5% of flowClass A Common StockSEC:0001567619-21-021618:0
281 shares@ US$148.38113.7% of flowClass A Common StockSEC:0001567619-21-021189:0
10,000 shares@ US$5.044.4% of flowClass A Common StockSEC:0001567619-21-019299:0
10,000 shares@ US$5.044.4% of flowClass A Common StockSEC:0001567619-21-017949:0
10,000 shares@ US$5.044.3% of flowClass A Common StockSEC:0001209191-21-054900:0
270 shares@ US$161.84753.7% of flowClass A Common StockSEC:0001209191-21-053392:0
10,000 shares@ US$5.044.3% of flowClass A Common StockSEC:0001209191-21-049650:0
25 of 29 declarations
